Fully Remote Program to be Offered Free for Female-Owned Small Businesses Impacted By the COVID-19 Pandemic
San Francisco, CA, April 15, 2020 — To meet the growing demand and need for mental health support during the ongoing COVID-19 pandemic, Feel Therapeutics is launching the Feel Relief Program which will be available to anyone experiencing increased stress or uncertainty. For the hardest-hit region, the company will offer the service free of charge specifically for female-owned small businesses gravely impacted in New York City. Anyone interested can apply here. The company’s vision is to remove the suffering caused by mental disorders and make mental health care easily accessible for all by using biomarkers and data-driven therapeutics.
The Feel Relief Program is a four-week, fully remote mental health support program. It is designed to help everyone manage excessive worry during the COVID-19 pandemic about their health, their new way of living or their financial future and turn anxiety into a balanced emotional state.
“Female entrepreneurs in New York City are under particularly severe stress,” says George Eleftheriou, CEO and Co-Founder of Feel Therapeutics. He continued, “They are likely to be bootstrapping their business and carrying higher debt loads. As a startup/small business ourselves, we want to do what we can to help.”
The program includes access to mental health resources, an app to journal emotions and complete mental health exercises, as well as weekly online 15-minute sessions with coaches. Feel coaches are trained to deliver the appropriate guidance to address individual issues such as work/life balance, working from home or grief counseling. Additionally, for corporate clients, the program will offer group mental health webinars for their employees in order to boost productivity and morale.
For those requiring more comprehensive mental health support, the company continues to offer its flagship Feel Program. Feel is a holistic mental health program that includes the Feel Emotion Sensor and offers constant support, 24/7 interventions and weekly sessions with a licensed therapist.
“We are experiencing unprecedented times of uncertainty and difficulty,” Eleftheriou said. “More than ever before, we need to protect our mental health, individually and collectively.”
Full details of the Feel Relief Program can be found here.
Feel Therapeutics, Inc. is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in the way we diagnose, manage, and care for Mental Health. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and has partnerships with large pharmaceutical companies to develop novel digital biomarkers and bring digital health solutions to market as standalone programs or alongside medications. Feel Therapeutics is headquartered in San Francisco, with additional offices in Europe. For more information, visit http://www.feeltherapeutics.com or contact us at info@feeltherapeutics.com.
